{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:46Z","timestamp":1793754346180,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["COV\/LTE\/20\/06"],"award-info":[{"award-number":["COV\/LTE\/20\/06"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29\u20133.58), palpitations (OR 2.51, OR 2.36\u20132.66), chest pain (OR 2.09, 95% CI 1.96\u20132.23), and confusion (OR 2.92, 95% CI 2.78\u20133.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.<\/jats:p>","DOI":"10.1038\/s41467-022-33415-5","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T06:03:17Z","timestamp":1665554597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":190,"title":["Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study"],"prefix":"10.1038","volume":"13","author":[{"given":"Claire E.","family":"Hastie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-9462","authenticated-orcid":false,"given":"Andrew J.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-7991","authenticated-orcid":false,"given":"Nicholas L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corri","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-3621","authenticated-orcid":false,"given":"David N.","family":"Blane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R.","family":"Ibbotson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-7035","authenticated-orcid":false,"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"33415_CR1","unstructured":"WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021)."},{"key":"33415_CR2","doi-asserted-by":"publisher","unstructured":"Domingo, F.R. et al. Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.06.03.21258317 (2021).","DOI":"10.1101\/2021.06.03.21258317"},{"key":"33415_CR3","doi-asserted-by":"crossref","unstructured":"Han, Q., Zheng, B., Daines, L., Sheikh, A. Long-term sequelae of covid-19: a systematic review and meta-analysis of one-year follow-up studies on post-covid symptoms. Pathogens. 11, 269 (2022).","DOI":"10.3390\/pathogens11020269"},{"key":"33415_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/fampra\/cmab076","volume":"39","author":"SAM van Kessel","year":"2022","unstructured":"van Kessel, S. A. M., Olde Hartman, T. C., Lucassen, P. & van Jaarsveld, C. H. M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pr. 39, 159\u2013167 (2022).","journal-title":"Fam. Pr."},{"key":"33415_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jmv.27309","volume":"94","author":"P Malik","year":"2022","unstructured":"Malik, P. et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J. Med Virol. 94, 253\u2013262 (2022).","journal-title":"J. Med Virol."},{"key":"33415_CR6","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).","journal-title":"EClinicalMedicine"},{"key":"33415_CR7","first-page":"e14357","volume":"75","author":"AL Cabrera Martimbianco","year":"2021","unstructured":"Cabrera Martimbianco, A. L., Pacheco, R. L., Bagattini, A. M. & Riera, R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J. Clin. Pr. 75, e14357 (2021).","journal-title":"Int J. Clin. Pr."},{"key":"33415_CR8","doi-asserted-by":"publisher","first-page":"e0259164","DOI":"10.1371\/journal.pone.0259164","volume":"16","author":"AN Poudel","year":"2021","unstructured":"Poudel, A. N. et al. Impact of Covid-19 on health-related quality of life of patients: a structured review. PLoS ONE 16, e0259164 (2021).","journal-title":"PLoS ONE"},{"key":"33415_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29521-z","volume":"13","author":"M Whitaker","year":"2022","unstructured":"Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13, 1957 (2022).","journal-title":"Nat. Commun."},{"key":"33415_CR10","unstructured":"Harrison, S., Walters, B., Simmons, Z., Cook, M., Clark, R. The effectiveness of vaccination against long COVID: a rapid evidence briefing. In: UK Health Security Agency DoHaSS, ed. London https:\/\/ukhsa.koha-ptfs.co.uk\/cgi-bin\/koha\/opac-detail.pl?biblionumber=64359 (2022)."},{"key":"33415_CR11","doi-asserted-by":"crossref","unstructured":"Aly-Aly, Z., Benjamin, B., Xie, Y. Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19. ResearchSquare https:\/\/www.researchsquare.com\/article\/rs-1062160\/v1 (2021).","DOI":"10.21203\/rs.3.rs-1062160\/v1"},{"key":"33415_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","volume":"22","author":"M Antonelli","year":"2022","unstructured":"Antonelli, M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 22, 43\u201355 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"33415_CR13","doi-asserted-by":"crossref","unstructured":"Kuodi, P. et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. npj Vaccines 7, 101. (2022).","DOI":"10.1038\/s41541-022-00526-5"},{"key":"33415_CR14","doi-asserted-by":"publisher","unstructured":"Senjam, S.S. et al. Assessment of post COVID-19 health problems and its determinants in North India: a descriptive cross section study. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.10.03.21264490 (2021).","DOI":"10.1101\/2021.10.03.21264490"},{"key":"33415_CR15","doi-asserted-by":"publisher","unstructured":"Simon, M.A., Luginbuhl, R.D., Parker, R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.11.17.21263608 (2021).","DOI":"10.1101\/2021.11.17.21263608"},{"key":"33415_CR16","doi-asserted-by":"crossref","unstructured":"Taquet, M., Dercon, Q., Harrison, P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 103, 154\u2013162 (2022).","DOI":"10.1016\/j.bbi.2022.04.013"},{"key":"33415_CR17","doi-asserted-by":"publisher","unstructured":"Arnold, D.T. et al. Are vaccines safe in patients with Long COVID? A prospective observational study. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.03.11.21253225 (2021).","DOI":"10.1101\/2021.03.11.21253225"},{"key":"33415_CR18","doi-asserted-by":"publisher","first-page":"e069676","DOI":"10.1136\/bmj-2021-069676","volume":"377","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani, D. et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 377, e069676 (2022).","journal-title":"BMJ"},{"key":"33415_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00296-021-04797-4","volume":"41","author":"N Cleaton","year":"2021","unstructured":"Cleaton, N. et al. The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding. Rheumatol. Int 41, 707\u2013714 (2021).","journal-title":"Rheumatol. Int"},{"key":"33415_CR20","first-page":"100170","volume":"2","author":"JM Janssen","year":"2021","unstructured":"Janssen, J. M. et al. Use of SMS-linked electronic surveys for COVID-19 case investigation and contact tracing - Marin County, CA, USA. Public Health Pr. (Oxf.) 2, 100170 (2021).","journal-title":"Public Health Pr. (Oxf.)"},{"key":"33415_CR21","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(21)00634-6","volume":"397","author":"R Mathur","year":"2021","unstructured":"Mathur, R. et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet 397, 1711\u20131724 (2021).","journal-title":"Lancet"},{"key":"33415_CR22","unstructured":"Scotland\u2019s Census: Ethnicity. https:\/\/www.scotlandscensus.gov.uk\/census-results\/at-a-glance\/ethnicity\/#:~:text=Scotland\u2019s%20population%20was%2096.0%25%20white,ethnic%20groups%20doubled%20to%204%25 (2011)."},{"key":"33415_CR23","unstructured":"Scottish Index of Multiple Deprivation https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/ (2020)."},{"key":"33415_CR24","unstructured":"HDR-UK. Phenotype Library. https:\/\/phenotypes.healthdatagateway.org\/phenotypes\/."},{"key":"33415_CR25","doi-asserted-by":"publisher","first-page":"e043887","DOI":"10.1136\/bmjopen-2020-043887","volume":"11","author":"L Sigfrid","year":"2021","unstructured":"Sigfrid, L. et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study protocol. BMJ Open 11, e043887 (2021).","journal-title":"BMJ Open"}],"updated-by":[{"DOI":"10.1038\/s41467-022-34344-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33415-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:06:59Z","timestamp":1667358419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33415"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33415-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1656915\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-022-34344-z","URL":"https:\/\/doi.org\/10.1038\/s41467-022-34344-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5663"}}